Category: carbapenem

Considerations Not Addressed in the FDA’s Communication Discussing Olympus’ New Instructions for Reprocessing the TJF-Q180V Duodenoscope

March 27, 2015 — On March 26, 2015, the FDA issued a safety communication: Olympus Validates New Reprocessing Instructions for Model TJF-Q180V Duodenoscopes — click here. This Olympus safety communication…

Lessons Taught by a Recent “Superbug” Outbreak: Could ‘Ex Post Facto’ Notification be Warranted?

April 21, 2014 — Advocate Lutheran General Hospital (Park Ridge, IL) in 2013 linked multiple patient infections and colonizations of carbapenem-resistant Enterobacteriaceae, or “CRE,” to contaminated gastrointestinal (GI) endoscopes. This…